As an outward-facing exchange, SGX, like Singapore itself, is reliant on the free flow of capital, something which may be negatively affected by deglobalization. SGX’s largest derivatives products are ...

Biocon (down 3.89%), Natco Pharma (down 2.39%), Divis Laboratories (down 1.8%), Mankind Pharma (down 1.69%), Aurobindo Pharma (down 1.3%), Alkem Laboratories (down 1.27%), Glenmark Pharmaceuticals ...